查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1305017

综合代谢面板测试市场：按疾病、测试类型、最终用户划分 - 全球预测 2023-2030

Comprehensive Metabolic Panel Testing Market by Disease, Test Type, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球综合代谢检测市场预计将在 2023 年大幅增长，达到 92,864.8 亿美元，年复合成长率为 10.63%，预计到 2030 年将达到惊人的 18,861.1 百万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球综合代谢组测试市场至关重要。通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的资讯。这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、积累和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通胀的累积影响。

5、竞争评估与资讯：对主要企业的市场份额、战略、产品、认证、法规状况、专利状况、製造能力等进行综合评价。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 综合代谢组检测的全球市场规模和预测是多少？

2.在预测期内，COVID-19 对全球综合代谢检测市场的抑制要素和影响有哪些？

3. 在预测期内，全球综合代谢组测试市场应投资哪些产品/细分市场/应用/领域？

4. 全球综合代谢组检测市场的竞争策略是什么？

5.全球综合代谢组检测市场的技术趋势和法律规范是什么？

6.全球综合代谢组检测市场主要厂商的市场份额是多少？

7. 哪些型态和战略倡议被认为适合进入全球综合代谢组检测市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病发病率增加
      • 人群存在早期诊断和治疗的潜在需求。
      • 老年人口不断增加，活检过程不断增加
    • 抑制因素
      • 测试给出错误结果的概率
    • 机会
      • 引入新的创新解决方案以提高效率并减少错误
      • 实验室自动化系统与生物信息学和资料管理解决方案的持续整合
    • 任务
      • 法规体系的变化在製造商之间造成了模糊性
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通胀的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户定制

第6章综合代谢组测试市场：按疾病分类

  • 糖尿病
  • 肾臟疾病
  • 肝病

第7章按测试类型分類的综合代谢组测试市场

  • 电解质
  • 葡萄糖
  • 肾臟测试
  • 肝功能检查
  • 蛋白质

第8章综合代谢组测试市场：按最终用户分类

  • 实验室
  • 示范实验

第9章美洲综合代谢组测试市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太综合代谢组测试市场

  • 澳大利亚
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲综合代谢组测试市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市场份额分析：主要企业
  • 竞争情景分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可和定价
Product Code: MRR-ED54C46E80C4

The Global Comprehensive Metabolic Panel Testing Market is forecasted to grow significantly, with a projected USD 9,286.48 million in 2023 at a CAGR of 10.63% and expected to reach a staggering USD 18,861.10 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Comprehensive Metabolic Panel Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Comprehensive Metabolic Panel Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Disease, market is studied across Diabetes, Kidney Disease, and Liver Disease. The Liver Disease is projected to witness significant market share during forecast period.

Based on Test Type, market is studied across Electrolytes, Glucose, Kidney Tests, Liver Functional Tests, and Proteins. The Proteins is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Laboratory and PoC. The Laboratory is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Comprehensive Metabolic Panel Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Comprehensive Metabolic Panel Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Comprehensive Metabolic Panel Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Comprehensive Metabolic Panel Testing Market?

4. What is the competitive strategic window for opportunities in the Global Comprehensive Metabolic Panel Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Comprehensive Metabolic Panel Testing Market?

6. What is the market share of the leading vendors in the Global Comprehensive Metabolic Panel Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Comprehensive Metabolic Panel Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Comprehensive Metabolic Panel Testing Market, by Disease, 2022 vs 2030
  • 4.3. Comprehensive Metabolic Panel Testing Market, by Test Type, 2022 vs 2030
  • 4.4. Comprehensive Metabolic Panel Testing Market, by End-User, 2022 vs 2030
  • 4.5. Comprehensive Metabolic Panel Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic diseases
      • 5.1.1.2. Potential need for early diagnosis and treatment among the population
      • 5.1.1.3. Rising elderly population coupled with increase in biopsy processes
    • 5.1.2. Restraints
      • 5.1.2.1. Probability of false results on testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging introduction of innovative solutions to improve efficiency and reduce errors
      • 5.1.3.2. Ongoing integration of automated systems in laboratories with bioinformatics and data management solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Changing regulatory system creating ambiguity among manufacturers
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Comprehensive Metabolic Panel Testing Market, by Disease

  • 6.1. Introduction
  • 6.2. Diabetes
  • 6.3. Kidney Disease
  • 6.4. Liver Disease

7. Comprehensive Metabolic Panel Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Electrolytes
  • 7.3. Glucose
  • 7.4. Kidney Tests
  • 7.5. Liver Functional Tests
  • 7.6. Proteins

8. Comprehensive Metabolic Panel Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Laboratory
  • 8.3. PoC

9. Americas Comprehensive Metabolic Panel Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Comprehensive Metabolic Panel Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Comprehensive Metabolic Panel Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. COMPREHENSIVE METABOLIC PANEL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2022 VS 2030 (%)
  • FIGURE 5. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
  • FIGURE 6. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. COMPREHENSIVE METABOLIC PANEL TESTING MARKET DYNAMICS
  • FIGURE 9. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. COMPREHENSIVE METABOLIC PANEL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 5. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY KIDNEY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LIVER DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY KIDNEY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LIVER FUNCTIONAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY POC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. COMPREHENSIVE METABOLIC PANEL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 145. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 146. COMPREHENSIVE METABOLIC PANEL TESTING MARKET LICENSE & PRICING